Date:9/7/2010

alysis catheters, their increasing adoption will support prices and revenues through 2014. Although chronic catheter adoption is awakening in Japan, the country shows no signs of adopting antimicrobial-coated devices, which are gaining popularity in other regions due to their ability to reduce infection rates. Antimicrobial devices were released in Japan in 2000, but several patients died as a result of severe adverse reactions to the coatings.  As a result, the MHLW removed the devices from the market and they have not been reintroduced.

MRG's Japanese Markets for Vascular Access Devices 2010 report provides critical insight into trends that will fuel market growth for short peripheral intravenous catheters, central venous catheters, implantable ports, dialysis catheters, and peripherally inserted central catheters through 2014.  

About Millennium Research GroupMillennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer behavior tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names co
'/>"/>

SOURCE Millennium Research Group Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Micromet Announces Changes in Management Team
3. Cancer Cure Coalition Proposes Major Changes at the FDA
4. Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis
5. Silence Therapeutics Announces Board Changes
6. Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies
7. Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin
8. Exercise Helps Prevent Age-Related Brain Changes in Older Adults
9. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
10. Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion
11. Diabetes Experts Issue New Recommendations for Inpatient Glycemic Control - Call for Systemic Changes in Hospitals Nationwide